Aspen Aerogels (NYSE:ASPN) Upgraded to Sell at StockNews.com

Aspen Aerogels (NYSE:ASPN) was upgraded by analysts at StockNews.com to a “sell” rating in a research note issued on Wednesday.

A number of other analysts also recently issued reports on the company. Seaport Res Ptn downgraded Aspen Aerogels from a “strong-buy” rating to a “hold” rating in a report on Wednesday, February 12th. Roth Mkm decreased their price target on Aspen Aerogels from $22.00 to $16.00 and set a “buy” rating for the company in a report on Friday, February 14th. Craig Hallum decreased their price target on Aspen Aerogels from $21.00 to $18.00 and set a “buy” rating for the company in a report on Friday, February 14th. Canaccord Genuity Group decreased their price target on Aspen Aerogels from $20.00 to $15.00 and set a “buy” rating for the company in a report on Friday, February 14th. Finally, Barclays decreased their price target on Aspen Aerogels from $27.00 to $25.00 and set an “overweight” rating for the company in a report on Tuesday, November 12th. One research analyst has rated the stock with a sell rating, one has issued a hold rating, eight have issued a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $24.67.

Aspen Aerogels Trading Down 1.0 %

ASPN opened at $8.55 on Wednesday. Aspen Aerogels has a 12 month low of $8.25 and a 12 month high of $33.15. The stock has a market capitalization of $701.12 million, a price-to-earnings ratio of 855.36 and a beta of 2.14. The company has a debt-to-equity ratio of 0.27, a current ratio of 2.93 and a quick ratio of 2.48. The business has a fifty day moving average price of $12.06 and a 200 day moving average price of $18.36.

Aspen Aerogels (NYSE:ASPN) last released its earnings results on Wednesday, February 12th. The construction company reported $0.15 EPS for the quarter, topping the consensus estimate of $0.04 by $0.11. Aspen Aerogels had a return on equity of 5.06% and a net margin of 0.36%. Sell-side analysts expect that Aspen Aerogels will post 0.12 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Aspen Aerogels

Institutional investors have recently added to or reduced their stakes in the stock. Quest Partners LLC increased its position in Aspen Aerogels by 263.3% in the 3rd quarter. Quest Partners LLC now owns 7,397 shares of the construction company’s stock valued at $205,000 after acquiring an additional 5,361 shares during the period. Sandia Investment Management LP acquired a new position in Aspen Aerogels in the 4th quarter valued at about $89,000. Pursue Wealth Partners LLC acquired a new position in Aspen Aerogels in the 3rd quarter valued at about $222,000. Mesirow Financial Investment Management Inc. acquired a new position in Aspen Aerogels in the 3rd quarter valued at about $252,000. Finally, Kovitz Investment Group Partners LLC acquired a new position in Aspen Aerogels in the 3rd quarter valued at about $263,000. Institutional investors and hedge funds own 97.64% of the company’s stock.

About Aspen Aerogels

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.